Skip to main content

Zimmer Biomet diluted shares

  • ZBH · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$103.21−1.29%Close 13 Nov 2026

Zimmer Biomet's diluted shares was 199M shares for fiscal year 2025 (the twelve months to 31 Dec 2025), down 2.6% from fiscal 2024.

In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was 191M shares, down 3.7% from a year earlier.

From Zimmer Biomet's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.

Fiscal 2025
199M
−2.6%
Q3 FY2026
191M
−3.7% on a year
Growth over 9 years
−0.2%
a year, FY 2016–FY 2025

Diluted shares by fiscal year

202MFY 2016204MFY 2017+0.6%204MFY 2018−0.1%207MFY 2019+1.6%207MFY 2020+0.1%210MFY 2021+1.6%210MFY 20220.0%210MFY 2023−0.3%204MFY 2024−2.8%199MFY 2025−2.6%

Change on the year before, under each year. From FY 2016 to FY 2025, Zimmer Biomet's diluted shares went from 202M shares to 199M shares, a compound annual change of −0.2%; the highest was 210M shares in FY 2021.

Zimmer Biomet diluted shares, fiscal years
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Diluted shares202M204M204M207M207M210M210M210M204M199M
Period end31 Dec 201631 Dec 201731 Dec 201831 Dec 201931 Dec 202031 Dec 202131 Dec 202231 Dec 202331 Dec 202431 Dec 2025

Diluted shares by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

Zimmer Biomet diluted shares, fiscal quarters
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Diluted shares200M200M198M199M198M196M193M191M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How diluted shares is measured

Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

Zimmer Biomet's other figures

Diluted shares of comparable companies

Everything on ZBH, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.